Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens

Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens

<p style="text-align:justify;"> <b>Background:</b> Kenya introduced a pentavalent vaccine including the DTP, Haemophilus influenzae type b and hepatitis b virus antigens in Nov 2001 and strengthened immunization services. We estimated immunization coverage before and aft...

Bibliografske podrobnosti
Main Authors:	Ndiritu, M, Cowgill, K, Ismail, A, Chiphatsi, S, Kamau, T, Fegan, G, Feikin, DR, Newton, C, Scott, J
Format:	Journal article
Jezik:	English
Izdano:	BioMed Central 2006

Podobne knjige/članki

Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new <it>Haemophilus influenzae </it>type b and hepatitis b virus antigens
od: Feikin Daniel R, et al.
Izdano: (2006-05-01)

Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.
od: Cowgill, K, et al.
Izdano: (2006)

The seroepidemiology of Haemophilus influenzae type b prior to introduction of an immunization programme in Kathmandu, Nepal
od: Marshall, A, et al.
Izdano: (2014)

The seroepidemiology of Haemophilus influenzae type b prior to introduction of an immunization programme in Kathmandu, Nepal.
od: Andrew S J Marshall, et al.
Izdano: (2014-01-01)

Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya.
od: Akumu, A, et al.
Izdano: (2007)

Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya
od: Angela Oloo Akumu, et al.
Izdano: (2007-07-01)

Haemophilus influenzae type b reemergence after combination immunization.
od: Johnson, N, et al.
Izdano: (2006)

Haemophilus influenzae Type b Reemergence after Combination Immunization
od: Nik G. Johnson, et al.
Izdano: (2006-06-01)

Association of non-type b Haemophilus influenzae with HIV
od: Karen Cowgill, et al.
Izdano: (2007-05-01)

Evaluation of haemophilus influenzae type b vaccine for routine immunization in Nepali infants.
od: Metz, J, et al.
Izdano: (2012)

Naturally acquired immunity to Haemophilus influenzae type B in healthy Cuban children
od: Gilda Toraño Peraza, et al.
Izdano: (2004-11-01)

The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi)
od: Paul T. King, et al.
Izdano: (2015-01-01)

Immune response of adults with secondary immunodeficiency to pediatric <it>Haemophilus influenzae</it> type b (Hib) vaccine
od: Ulanova Marina, et al.
Izdano: (2011-11-01)

Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.
od: Barbour, M, et al.
Izdano: (1993)

Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study
od: Dr. Laura L Hammitt, MD, et al.
Izdano: (2016-03-01)

Immunization of HIV-infected adults in the UK with Haemophilus influenzae b/meningococcal C glycoconjugate and pneumococcal polysaccharide vaccines
od: MacLennan, C, et al.
Izdano: (2016)

Simulating Immune Interference on the Effect of a Bivalent Glycoconjugate Vaccine against Haemophilus influenzae Serotypes “a” and “b”
od: Angjelina Konini, et al.
Izdano: (2016-01-01)

Systematic Evaluation of the Distribution of Immune Cells following Subcutaneous Administration of Haemophilus Influenzae Type B Vaccine to Mice
od: Yao He, et al.
Izdano: (2023-10-01)

Rapid Assessment Tool for Haemophilus influenzae type b Disease in Developing Countries
od: Daniel R. Feikin, et al.
Izdano: (2004-07-01)

Expanded Programme On Immunization-An Integrated Approach
od: Ko Ko U
Izdano: (1990-01-01)

Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in mice.
od: Sandro Roier, et al.
Izdano: (2012-01-01)

RNA thermosensors facilitate Streptococcus pneumoniae and Haemophilus influenzae immune evasion
od: Eichner, Hannes, et al.
Izdano: (2022)

Epithelial immune activation and intracellular invasion by non-typeable Haemophilus influenzae
od: Brown, MA, et al.
Izdano: (2023)

Epithelial immune activation and intracellular invasion by non-typeable Haemophilus influenzae
od: Mary A. Brown, et al.
Izdano: (2023-04-01)

RNA thermosensors facilitate Streptococcus pneumoniae and Haemophilus influenzae immune evasion.
od: Hannes Eichner, et al.
Izdano: (2021-04-01)

The impact of residency and urbanicity on Haemophilus influenzae Type b and pneumococcal immunization in Shanghai Children: a Retrospective Cohort Study.
od: Abram L Wagner, et al.
Izdano: (2014-01-01)

Chemically Synthesized Alcaligenes Lipid A as an Adjuvant to Augment Immune Responses to Haemophilus Influenzae Type B Conjugate Vaccine
od: Zilai Liu, et al.
Izdano: (2021-10-01)

Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster.
od: Perrett, K, et al.
Izdano: (2014)

Correction: Intranasal Immunization with Nontypeable Haemophilus influenzae Outer Membrane Vesicles Induces Cross-Protective Immunity in Mice
Izdano: (2012-01-01)

SAFETY OF PEDIATRIC COMBINATED VACCINE FOR DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZA TYPE B IN THE PRIMARY IMMUNIZATION AND FIRST BOOSTERISATION
od: N. D. Chernova, et al.
Izdano: (2012-08-01)

Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b
od: Nadia A. Charania, et al.
Izdano: (2017-09-01)

Haemophilus influenzae type b conjugate vaccines
od: Kelly, D, et al.
Izdano: (2004)

Haemophilus influenzae type b conjugate vaccines.
od: Kelly, D, et al.
Izdano: (2004)

Is Haemophilus influenzae type b disease finished?
od: Kelly, D, et al.
Izdano: (2004)

Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.
od: Kelly, D, et al.
Izdano: (2009)

Beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b meningitis in partially immunized immunocompetent child: a case report
od: Majid Ali Qureshi, et al.
Izdano: (2021-08-01)

Lung Surfactant Lipids Provide Immune Protection Against Haemophilus influenzae Respiratory Infection
od: Belén García-Fojeda, et al.
Izdano: (2019-03-01)

Pellino-1 Regulates Immune Responses to Haemophilus influenzae in Models of Inflammatory Lung Disease
od: Bethany M. Hughes, et al.
Izdano: (2019-07-01)

A SURVEY ON THE REASONS FOR NOT BEGINNING OR COMPLETING THE IMMUNIZATION SCHEDULE OF THE EXPANDED PROGRAMME ON IMMUNIZATION IN IRAN
od: K.Nasseri, et al.
Izdano: (1986-12-01)

Comparative Analysis of Measles Morbidity and Mortality in Calabar during the Expanded Programme on Immunization and the National Programme on Immunization Eras
od: Etuk IS, et al.
Izdano: (2024-07-01)